| Original language | English |
|---|---|
| Pages (from-to) | 620-622 |
| Number of pages | 3 |
| Journal | Alimentary Pharmacology and Therapeutics |
| Volume | 50 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2019 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Alimentary Pharmacology and Therapeutics, Vol. 50, No. 5, 2019, p. 620-622.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Letter
T2 - Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis
AU - Schnadower, David
AU - Tarr, Phillip I.
AU - Freedman, Stephen B.
N1 - Funding Information: Declaration of personal and funding interests: Dr Schnadower: research grant support from the NICHD (#RO1 HD071915) and NIAID and support from the Richard and Barbara Ruddy Research Chair in Pediatric Emergency Medicine at Cincinnati Children's Hospital Medical Center. Dr Tarr: research and training grant support from the NIAD, NIDDK, NICHD, CDC, USAID, Bill & Melinda Gates Foundation, and SPARC. Consultant to Bill & Melinda Gates Foundation, Takeda Pharmaceuticals, Bio-Rad, MediBeacon Inc Member of the Data Safety Monitoring Board of Inmunova. Compensation for editorial roles or for authorship from Wiley and UpToDate. Member of the Scientific Advisory Board of MediBeacon Inc Owner of equity in MediBeacon Inc Inventor of a patent assigned to MediBeacon Inc (US20150147277A1, Compositions and methods for assessing gut function) which might generate royalties in the future. Dr Freedman: research grant support from NICHD, NIAID, CIHR and support from the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness. Has served as an advisory board member for Takeda Pharmaceutical Company Ltd. Compensation for authorship from UpToDate.
PY - 2019
Y1 - 2019
UR - http://www.scopus.com/inward/record.url?scp=85070681810&partnerID=8YFLogxK
U2 - 10.1111/apt.15418
DO - 10.1111/apt.15418
M3 - Letter
C2 - 31414542
AN - SCOPUS:85070681810
SN - 0269-2813
VL - 50
SP - 620
EP - 622
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 5
ER -